Literature DB >> 23152369

Human T-cells directed to seasonal influenza A virus cross-react with 2009 pandemic influenza A (H1N1) and swine-origin triple-reassortant H3N2 influenza viruses.

Marine L B Hillaire1, Stella E Vogelzang-van Trierum1, Joost H C M Kreijtz1, Gerrie de Mutsert1, Ron A M Fouchier1, Albert D M E Osterhaus2,1, Guus F Rimmelzwaan2,1.   

Abstract

Virus-specific CD8(+) T-cells contribute to protective immunity against influenza A virus (IAV) infections. As the majority of these cells are directed to conserved viral proteins, they may afford protection against IAVs of various subtypes. The present study assessed the cross-reactivity of human CD8(+) T-lymphocytes, induced by infection with seasonal A (H1N1) or A (H3N2) influenza virus, with 2009 pandemic influenza A (H1N1) virus [A(H1N1)pdm09] and swine-origin triple-reassortant A (H3N2) [A(H3N2)v] viruses that are currently causing an increasing number of human cases in the USA. It was demonstrated that CD8(+) T-cells induced after seasonal IAV infections exerted lytic activity and produced gamma interferon upon in vitro restimulation with A(H1N1)pdm09 and A(H3N2)v influenza A viruses. Furthermore, CD8(+) T-cells directed to A(H1N1)pdm09 virus displayed a high degree of cross-reactivity with A(H3N2)v viruses. It was concluded that cross-reacting T-cells had the potential to afford protective immunity against A(H1N1)pdm09 viruses during the pandemic and offer some degree of protection against infection with A(H3N2)v viruses.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23152369     DOI: 10.1099/vir.0.048652-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  27 in total

1.  Influenza B virus-specific CD8+ T-lymphocytes strongly cross-react with viruses of the opposing influenza B lineage.

Authors:  Carolien E van de Sandt; YingYing Dou; Stella E Vogelzang-van Trierum; Kim B Westgeest; Mark R Pronk; Albert D M E Osterhaus; Ron A M Fouchier; Guus F Rimmelzwaan; Marine L B Hillaire
Journal:  J Gen Virol       Date:  2015-04-21       Impact factor: 3.891

2.  Cellular immune correlates of protection against symptomatic pandemic influenza.

Authors:  Saranya Sridhar; Shaima Begom; Alison Bermingham; Katja Hoschler; Walt Adamson; William Carman; Thomas Bean; Wendy Barclay; Jonathan J Deeks; Ajit Lalvani
Journal:  Nat Med       Date:  2013-09-22       Impact factor: 53.440

3.  Structural and Biochemical Analyses of Swine Major Histocompatibility Complex Class I Complexes and Prediction of the Epitope Map of Important Influenza A Virus Strains.

Authors:  Shuhua Fan; Yanan Wu; Song Wang; Zhenbao Wang; Bo Jiang; Yanjie Liu; Ruiying Liang; Wenzhong Zhou; Nianzhi Zhang; Chun Xia
Journal:  J Virol       Date:  2016-07-11       Impact factor: 5.103

4.  Human cytotoxic T lymphocytes directed to seasonal influenza A viruses cross-react with the newly emerging H7N9 virus.

Authors:  Carolien E van de Sandt; Joost H C M Kreijtz; Gerrie de Mutsert; Martina M Geelhoed-Mieras; Marine L B Hillaire; Stella E Vogelzang-van Trierum; Albert D M E Osterhaus; Ron A M Fouchier; Guus F Rimmelzwaan
Journal:  J Virol       Date:  2013-11-20       Impact factor: 5.103

5.  In vitro assessment of the immunological significance of a human monoclonal antibody directed to the influenza a virus nucleoprotein.

Authors:  Rogier Bodewes; Martina M Geelhoed-Mieras; Jens Wrammert; Rafi Ahmed; Patrick C Wilson; Ron A M Fouchier; Albert D M E Osterhaus; Guus F Rimmelzwaan
Journal:  Clin Vaccine Immunol       Date:  2013-06-12

6.  Analysis of the affinity of influenza A virus protein epitopes for swine MHC I by a modified in vitro refolding method indicated cross-reactivity between swine and human MHC I specificities.

Authors:  Shuhua Fan; Yongli Wang; Xian Wang; Li Huang; Yunxia Zhang; Xiaomeng Liu; Wenshuai Zhu
Journal:  Immunogenetics       Date:  2018-07-10       Impact factor: 2.846

Review 7.  Innate and adaptive T cells in influenza disease.

Authors:  Simone Nüssing; Sneha Sant; Marios Koutsakos; Kanta Subbarao; Thi H O Nguyen; Katherine Kedzierska
Journal:  Front Med       Date:  2018-01-20       Impact factor: 9.927

Review 8.  Development of cross-protective influenza a vaccines based on cellular responses.

Authors:  Peter Christiaan Soema; Elly van Riet; Gideon Kersten; Jean-Pierre Amorij
Journal:  Front Immunol       Date:  2015-05-15       Impact factor: 7.561

Review 9.  Developing Universal Influenza Vaccines: Hitting the Nail, Not Just on the Head.

Authors:  Lidewij C M Wiersma; Guus F Rimmelzwaan; Rory D de Vries
Journal:  Vaccines (Basel)       Date:  2015-03-26

Review 10.  Measuring Cellular Immunity to Influenza: Methods of Detection, Applications and Challenges.

Authors:  Lynda Coughlan; Teresa Lambe
Journal:  Vaccines (Basel)       Date:  2015-04-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.